Form 4 Tracker
Tarsus Pharmaceuticals, Inc.
TARS

51 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 18, 2026Mar 18 8:17 PMAzamian Bobak R.
Proposed Sale
11,667$68.71$801.6K—

View →

Mar 18, 2026Mar 18 8:17 PMNeervannan Seshadri
Proposed Sale
3,610$68.71$248.0K—

View →

Mar 18, 2026Mar 18 8:14 PMFarrow Jeffrey S
Proposed Sale
2,133$68.71$146.6K—

View →

Mar 18, 2026Mar 18 8:13 PMMottiwala Aziz
Proposed Sale
4,330$68.71$297.5K—

View →

Mar 18, 2026Mar 18 8:11 PMLin Elizabeth Yeu
Proposed Sale
379$68.71$26.0K—

View →

Mar 16, 2026Mar 18 8:11 PMPhd J Link WilliamDirector
Sale
12,500$68.79$859.8K116,332(D)

View →

Mar 17, 2026Mar 17 8:09 PMAzamian Bobak R.
Proposed Sale
10,972$69.41$761.6K—

View →

Mar 17, 2026Mar 17 8:07 PMNeervannan Seshadri
Proposed Sale
3,125$69.41$216.9K—

View →

Mar 17, 2026Mar 17 8:03 PMFarrow Jeffrey S
Proposed Sale
2,111$69.41$146.5K—

View →

Mar 17, 2026Mar 17 7:59 PMWahl Bryan
Proposed Sale
4,084$69.41$283.5K—

View →

Mar 17, 2026Mar 17 7:55 PMWhitfield Dianne C.
Proposed Sale
4,029$69.41$279.7K—

View →

Mar 17, 2026Mar 17 7:47 PMLin Elizabeth Yeu
Proposed Sale
375$69.41$26.0K—

View →

Mar 17, 2026Mar 17 7:42 PMMottiwala Aziz
Proposed Sale
4,286$69.41$297.5K—

View →

Mar 16, 2026Mar 16 9:39 PMWILLIAM J LINK
Proposed Sale
12,500$68.78$859.8K—

View →

Mar 4, 2026Mar 5 9:03 PMSeshadri NeervannanChief Operating Officer
Sale
8,366$76.67$641.4K70,817(D)

View →

Mar 4, 2026Mar 4 3:56 PMNeervannan Seshadri
Proposed Sale
8,366$76.67$641.4K—

View →

Jan 2, 2026Jan 2 4:22 PMWhitfield Dianne C.
Proposed Sale
15,565$81.38$1.3M—

View →

Dec 24, 2025Dec 29 5:22 PMBOBAK AZAMIAN
Proposed Sale
6,000$82.51$495.1K—

View →

Dec 16, 2025Dec 16 8:12 PMLin Elizabeth Yeu
Proposed Sale
2,078$79.50$165.2K—

View →

Dec 16, 2025Dec 16 3:11 PMWhitfield Dianne C.
Proposed Sale
7,397$80.10$592.5K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 15, 2026Sep 17 8:47 PMI E Pyott DavidDirector
Option Exercise
201—605(D)

View →

Sep 15, 2026Sep 17 8:22 PMWendy L YarnoDirector
Option Exercise
302—907(D)

View →

Sep 15, 2026Sep 17 8:22 PMPhd J Link WilliamDirector
Option Exercise
201—605(D)

View →

Jun 25, 2026Jun 29 8:32 PMKatherine GoodrichDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMAndrew D. GoldbergDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMScott W MorrisonDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMBhaskar ChaudhuriDirector
Grant/Award
6,254$64.342,417(D)

View →

Jun 25, 2026Jun 29 8:31 PMWendy L YarnoDirector
Grant/Award
7,463$64.341,209(D)

View →

Jun 25, 2026Jun 29 8:30 PMI E Pyott DavidDirector
Grant/Award
7,060$64.34806(D)

View →

Jun 25, 2026Jun 29 8:30 PMPhd J Link WilliamDirector
Grant/Award
7,060$64.34806(D)

View →

Jun 15, 2026Jun 17 8:17 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Option Exercise
27,881—27,882(D)

View →

Jun 12, 2026Jun 16 8:06 PMScott W MorrisonDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:06 PMPhd J Link WilliamDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:06 PMBhaskar ChaudhuriDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:05 PMKatherine GoodrichDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:05 PMWendy L YarnoDirector
Option Exercise
2,954—0(D)

View →

Jun 12, 2026Jun 16 8:05 PMAndrew D. GoldbergDirector
Option Exercise
2,954—0(D)

View →

Apr 24, 2026Apr 28 8:23 PMI E Pyott DavidDirector
Option Exercise
1,383—0(D)

View →

Mar 15, 2026Mar 17 8:40 PMDianne C. WhitfieldChief Human Resources Officer
Option Exercise
23,909—15,067(D)

View →

Mar 15, 2026Mar 17 8:38 PMBryan WahlGeneral Counsel
Option Exercise
24,236—15,067(D)

View →

Page 1 of 2

Next →